Oppenheimer & Close’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-53,278
Closed -$4.97M 52
2015
Q3
$4.97M Buy
53,278
+960
+2% +$92.9K 4.23% 9
2015
Q2
$5.1M Sell
52,318
-880
-2% -$88.1K 4.24% 10
2015
Q1
$5.35M Hold
53,198
4.51% 7
2014
Q4
$5.56M Sell
53,198
-300
-0.6% -$31.6K 4.67% 7
2014
Q3
$5.7M Sell
53,498
-320
-0.6% -$33.2K 4.67% 7
2014
Q2
$5.63M Sell
53,818
-64
-0.1% -$6.47K 4.53% 8
2014
Q1
$5.29M Sell
53,882
-235
-0.4% -$21.8K 4.42% 9
2013
Q4
$4.96M Sell
54,117
-12,235
-18% -$1.13M 4.28% 10
2013
Q3
$5.75M Sell
66,352
-11,057
-14% -$992K 4.1% 10
2013
Q2
$6.65M Buy
+77,409
New +$6.57M 4.9% 8

Other funds holding JNJ

Oppenheimer & Close's JNJ Position: Q4 2015 in Review

Oppenheimer & Close sold out of Johnson & Johnson (JNJ) in Q4 2015, closing a stake of 53,278 shares — an estimated $4.97M sold.

Oppenheimer & Close first reported a position in JNJ in Q2 2013 and held it in 10 quarters. The position peaked at $6.65M in Q2 2013. 2,193 funds tracked by Wall St. Rank hold JNJ as of Q4 2015.

  • Oppenheimer & Close reported no remaining Johnson & Johnson position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Close sold 53,278 Johnson & Johnson shares in Q4 2015, an estimated $4.97M.
  • Oppenheimer & Close first reported a position in Johnson & Johnson in Q2 2013 and held it in 10 quarters.
  • Oppenheimer & Close's Johnson & Johnson position peaked at $6.65M in Q2 2013.
  • 2,193 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2015.

Based on Oppenheimer & Close's 13F filing for Q4 2015, filed 10 Feb 2016.